Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2020

Mar 2, 2020

29871_dirs_2020-03-02_0107bd0b-a4c9-4bb2-91b1-31bc254eb07f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2020-02-28

Reporting Person: Holzrichter Julie (Sr MD Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-28 Common Stock Class A S 3061 $203.37 Disposed 37284 Direct

Footnotes

F1: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

F2: On February 28, 2020, Ms. Holzrichter sold an aggregate of 3,061 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $199.46 to $199.82; $200.01 to $200.5; $205 to $205.98; $206.13 to $206.57; $207.34 to $207.72; and $208.54. The Company maintains a record of the transactions and copies will be provided upon request.